NSEUpdates25 Jun 2026 · 25 Jun 2026, 09:32 pm
Updates
Gaudium IVF and Women Health Limited · GAUDIUMIVF
✦ AI SummaryResults
Gaudium IVF and Women Health Limited has submitted a corrigendum to its financial results for the quarter and year ended March 31, 2026, correcting inadvertent regrouping and typographical errors in the comparative figures for the previous financial year ended March 31, 2025.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gaudium IVF and Women Health Limited has informed the Exchange regarding 'Corrigendum to the Financial Results submitted for the quarter and year ended March 31, 2026'.
Attachments (1)
📄pdf
Download →
GAUDIUM_25062026213135_Corrigendum_FR_26.pdf
View document text
3 gaudium® IVF
Delivering Motherhood Dreams
June 25,2026
BSE Limited National Stock Exchange of India Limited
Phiroze Jeejeebhoy Towers, Dalal Exchange Plaza, C-1, Block G,
Street, Fort, Bandra Kurla Complex, Bandra (E),
Mumbai — 400001, Maharashtra Mumbai — 400051, Maharashtra
Scrip Code — 544709 Symbol - GAUDIUMIVF
ISIN: INEOP8B01020 ISIN: INEOP8B01020
Sub: Corrigendum to the Financial Results for the Quarter and Year ended March 31, 2026
Ref: Regulation 30 & 33 of the Securities and Exchange Board of India (Listing Obligations and
Disclosure Requirements) Regulations, 2015
Dear Sir/Madam,
This Corrigendum is in relation to the Consolidated Financial Results of Gaudium IVF and Women Health
Limited ("Company") for the quarter and year ended March 31, 2026, submitted to the BSE Limited and National
Stock Exchange Limited (“Stock Exchanges”) vide our letter dated May 28, 2026.
Subsequent to the filing, it has been observed that certain inadvertent regrouping and typographical errors have
occurred in the comparative figures relating to the previous financial year ended March 31, 2025, appearing in
the Consolidated Balance Sheet and the Consolidated Statement of Profit and Loss forming part of the
Consolidated Financial Results for the quarter and year ended March 31, 2026.
These comparative figures relate to the financial year ended March 31, 2025 and have been presented alongside
the financial results for the current financial year ended March 31, 2026. The aforesaid errors are purely related
to regrouping and / or clerical in nature. The Company is voluntarily submitting this Corrigendum to rectify the
aforesaid inadvertent errors.
It is clarified that:
(1) The standalone financial results were reported correctly, and the changes relate only to the consolidated
financial results;
(2) Since the figures pertain to March 31, 2025, the overall figures for March 31, 2026 remain unchanged,
whether in standalone or consolidated financial results; and
(3) The aggregate figures of Current Assets as well as of Current Liabilities remain unchanged; and
(4) There is no change in the Standalone or Consolidated Statement of Cash Flows.
Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Pvt. Ltd.)
Registered Office : B1/51, Janakpuri, New Delhi- 110058 | Ph: 011-4885 8585
CIN : L85100DL2015PLC278296 Email : info@gaudiumivfcentre.com Website : www.gaudiumivfcentre.com E.%E}
1 gaudium® IVF
Delivering Motherhood Dreams
The details of the corrections are as follows:
A. Consolidated Balance Sheet — Current Assets
Particulars Correct Figure (% in
As Reported (Z in Lakhs)
Lakhs)
As at March 31, 2025 As at March 31,2025
Current Assets
Other Financial Assets 257.08 470.50
Other Current Assets 39231 178.89
Total Current Assets 5380.56 5380.56
B. Consolidated Balance Sheet — Current Liabilities
Particulars Correct Figure (X in
As Reported (% in Lakhs)
Lakhs)
As at March 31, 2025 As at March 31, 2025
Current Liabilities
Total Outstanding dues other than micro and small 1383.02 1408.43
enterprises
Other Financial Liabilities 2.24 63.43
Other Current Liabilities 97.42 20.41
Provisions 15.15 5.55
| Total Current Liabilities 3801.08 3801.08
C. Statement of Profit and Loss
Particulars Correct Figure (T in
As Reported (X in Lakhs)
Lakhs)
For the year ended March For the year ended
31,2025 March 31, 2025
Tax Expense
Current Tax 608.76 613.27
Deferred Tax 16.24 11.61
Total Tax Expense 625.00 624.88
Profit for the year from continuing operations 1917.73 1917.86
Total Comprehensive income for the year 1931.00 1931.13
Profit After Tax (PAT) for the previous year ended March 31, 2025, has been stated as ¥1,913.00
Lakhs instead of the correct figure of 1,913.13 Lakhs, constituting a minor under-reporting of 20.13 Lakh.
S Womg
E |New Delhi) 5
Gaudium IVF and Women Health Limited (rormerly knb%fi;G_ale/FVFand Women Health Pvt. Ltd.)
Registered Office : B1/51, Janakpuri, New Delhi- 110058 885 8585
CIN : L85100DL2015PLC278296 Email : info@gaudiumivfcentre.com Website : www.gaudiumivfcentre.com E].§EI
gaudium® IVF
Delivering Motherhood Dreams
‘We would also like to draw your attention to the fact that the correct PAT figure for the FY 2024-25 0f%1,913.13
Lakhs had already been duly reported in the financial results for the quarter ended December 31, 2025, filed
with the stock exchanges on March 18, 2026, which further substantiates that the figure of ¥1,913.00 Lakhs
appearing in the current filing is purely a typographical error.
‘We wish to clarify that the rectification of the aforesaid error does not have any impact on the Profit After Tax,
Net Worth, or the overall financial position of the Company for the quarter and year ended March 31, 2026.
There is no other change in the Consolidated Financial Results other than as stated above.
The Company has also received a confirmation letter dated June 25, 2026 from M/s. S K G N & Associates LLP,
Chartered Accountants, Statutory Auditors of the Company, confirming that the proposed rectifications are
limited to comparative figures relating to the financial year ended March 31, 2025 and accordingly, do not
necessitate any modification, revision, re-issuance or update of the Independent Auditor's Report dated May 28,
2026. The said Independent Auditor's Report therefore continues to remain valid and unchanged in all respects.
Further, it is informed that the Company had published a newspaper advertisement as per Regulation 47 of SEBI
Listing Regulations on May 29, 2026, containing only a QR code through which the financial results are
accessible. Simultaneous to this intimation, the Company is also replacing the updated financial results, with
changes incorporated as mentioned in this intimation along with the Auditors Report (as attached in Annexure
I to this intimation), on its website to be accessible through the QR code, to reflect the true, fair and complete
picture oft he financial position of the Company.
The aforesaid rectification of inadvertent regrouping and typographical errors has been approved by the Board
of Directors of the Company at its meeting held on June 25, 2026, based on the recommendation of the Audit
Committee.
The corrected comparative figures contained in this Corrigendum continue to present a true and fair view of the
financial position of the Company and are in compliance with the applicable Accounting Standards and the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015.
You are kindly requested to take the above on record.
Thanking you,
Yours faithfully,
For and on behalf of Gaudium IVF and Women Health Limited
(Formerly known as Gaudium IVF and Women Health Private Limited)
Naveen Kumar
Company Secretary and Compliance Officer
Membership No: A69788
Encl: a\a
Gaudium IVF and Women Health Limited (Formerly known as Gaudium IVF and Women Health Pvt. Ltd.)
Registered Office : B1/51, Janakpuri, New Delhi- 110058 | Ph: 011-4885 8585
CIN : L85100DL2015PLC278296 Email : info@gaudiumivfcentre.com Website : www.gaudiumivfcentre.com [El#E[E]
SXK G N & Associates LLP
INDIA Chartered Accountants
Independent Auditor’s Report on the Quarterly and Year to Date Audited Standalone
Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015, as amended
The Board of Directors of
Gaudium IVF and Women Health Limited (formerly known as Gaudium IVF and Women
Health Private Limited)
Report on the audit of the Standalone Financial Results
Opinion
We have audited the accompanying statement of quarterly and year to date standalone financial
results of Gaudium IVF and Women Health Limited (the “Company”) for the quarter ended March
31, 2026 and for the year ended March 31, 2026 (“Statement”), attached herewith, being submitted
by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015, as amended (the “Listing Regulations”).
[Showing first 8,000 characters — download PDF for full document]